Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin S Turpin

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Surgical Infections|March 28, 2008
Cost analysis of five antimicrobial regimens for the treatment of intra-abdominal infectionJohn G Carson, Robin S Turpin, Henry Hu, et al.
The Gerontologist|October 24, 2024
Delineating Care Recipient Burden Constructs: Development and Validation of the CARE-2B Scale for Care Recipient Self-Perceived Burden and Proxy Assessment of Caregiver BurdenMaja Kuharic, Brendan Mulhern, Lisa K Sharp, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2024
Comparison of the EQ-HWB and EQ-HWB-S With Other Preference-Based Measures Among United States Informal CaregiversMaja Kuharic, Brendan Mulhern, Lisa K Sharp, et al.
Journal of Managed Care & Specialty Pharmacy|March 30, 2016
Cost Comparison of Urate-Lowering Therapies in Patients with Gout and Moderate-to-Severe Chronic Kidney DiseaseGhaith Mitri, Eric T Wittbrodt, Robin S Turpin, et al.
International Journal of Antimicrobial Agents|March 8, 2007
Economic analysis of inadequate fluconazole therapy in non-neutropenic patients with candidaemia: a multi-institutional studyKevin W Garey, Robin S Turpin, David T Bearden, et al.
Clinical Therapeutics|October 26, 2006
Adherence to infectious diseases society of America guidelines for empiric therapy for patients with community-acquired pneumonia in a commercially insured cohortJasmanda H Wu, David H Howard, John E McGowan, et al.
The American Surgeon|February 14, 2006
Does initial choice of antimicrobial therapy affect length of stay for patients with complicated intra-abdominal infections?Samuel Eric Wilson, Robin S Turpin, X Henry Hu, et al.
Applied Health Economics and Health Policy|July 19, 2011
Nutrition therapy cost analysis in the US: pre-mixed multi-chamber bag vs compounded parenteral nutritionRobin S Turpin, Todd Canada, Frank Xiaoqing Liu, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|November 3, 2011
Bloodstream infections in patients receiving manufactured parenteral nutrition with vs without lipids: is the use of lipids really deleterious?Alessandro Pontes-Arruda, Frank Xiaoqing Liu, Robin S Turpin, et al.
Current Medical Research and Opinion|May 24, 2007
High- versus low-dose fluconazole therapy for empiric treatment of suspected invasive candidiasis among high-risk patients in the intensive care unit: a cost-effectiveness analysisHua Chen, Katie J Suda, Robin S Turpin, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Surgical Infections|March 28, 2008
Cost analysis of five antimicrobial regimens for the treatment of intra-abdominal infectionJohn G Carson, Robin S Turpin, Henry Hu, et al.
The Gerontologist|October 24, 2024
Delineating Care Recipient Burden Constructs: Development and Validation of the CARE-2B Scale for Care Recipient Self-Perceived Burden and Proxy Assessment of Caregiver BurdenMaja Kuharic, Brendan Mulhern, Lisa K Sharp, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2024
Comparison of the EQ-HWB and EQ-HWB-S With Other Preference-Based Measures Among United States Informal CaregiversMaja Kuharic, Brendan Mulhern, Lisa K Sharp, et al.
Journal of Managed Care & Specialty Pharmacy|March 30, 2016
Cost Comparison of Urate-Lowering Therapies in Patients with Gout and Moderate-to-Severe Chronic Kidney DiseaseGhaith Mitri, Eric T Wittbrodt, Robin S Turpin, et al.
International Journal of Antimicrobial Agents|March 8, 2007
Economic analysis of inadequate fluconazole therapy in non-neutropenic patients with candidaemia: a multi-institutional studyKevin W Garey, Robin S Turpin, David T Bearden, et al.
Clinical Therapeutics|October 26, 2006
Adherence to infectious diseases society of America guidelines for empiric therapy for patients with community-acquired pneumonia in a commercially insured cohortJasmanda H Wu, David H Howard, John E McGowan, et al.
The American Surgeon|February 14, 2006
Does initial choice of antimicrobial therapy affect length of stay for patients with complicated intra-abdominal infections?Samuel Eric Wilson, Robin S Turpin, X Henry Hu, et al.
Applied Health Economics and Health Policy|July 19, 2011
Nutrition therapy cost analysis in the US: pre-mixed multi-chamber bag vs compounded parenteral nutritionRobin S Turpin, Todd Canada, Frank Xiaoqing Liu, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|November 3, 2011
Bloodstream infections in patients receiving manufactured parenteral nutrition with vs without lipids: is the use of lipids really deleterious?Alessandro Pontes-Arruda, Frank Xiaoqing Liu, Robin S Turpin, et al.
Current Medical Research and Opinion|May 24, 2007
High- versus low-dose fluconazole therapy for empiric treatment of suspected invasive candidiasis among high-risk patients in the intensive care unit: a cost-effectiveness analysisHua Chen, Katie J Suda, Robin S Turpin, et al.
Pageof 4